Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 18:07 (1121 d 08:50 ago) – Posting: # 21893
Views: 7,018

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
22,759 posts in 4,775 threads, 1,627 registered users;
11 visitors (0 registered, 11 guests [including 6 identified bots]).
Forum time: 02:58 CEST (Europe/Vienna)

A refund for defective software might be nice,
except it would bankrupt the entire software industry
in the first year.    Andrew S. Tanenbaum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5